Benjamin J. Chen
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- CAR-T cell therapy research
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Viral-associated cancers and disorders 3
- CAR-T cell therapy research 2
-
- Single-cell and spatial transcriptomics 3
- Co-authors
- Christopher D.�M. Fletcher (2 shared papers)Scott J. Rodig (3 shared papers)Hongbo Yu (3 shared papers)Margaretha G.M. Roemer (1 shared paper)Bjoern Chapuy (1 shared paper)Margaret A. Shipp (1 shared paper)Jing Ouyang (1 shared paper)Mina L. Xu (1 shared paper)
- Journals
- The American Journal of Surgical Pathology (2 papers)Oncotarget (2 papers)Clinical Cancer Research (1 paper)Scientific Reports (1 paper)Cytopathology (1 paper)
- Partner nations
- United StatesNetherlandsRussia
In The Last Decade
Benjamin J. Chen
19 papers receiving 1.3k citations
Benjamin J. Chen's Hit Papers
Peers
Comparison fields: 5 of 67
- Pathology and Forensic Medicine 548
- Oncology 820
- Immunology 495
- Genetics 105
- Rheumatology 146
Countries citing papers authored by Benjamin J. Chen
This map shows the geographic impact of Benjamin J. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Chen more than expected).
Fields of papers citing papers by Benjamin J. Chen
This network shows the impact of papers produced by Benjamin J. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Chen. The network helps show where Benjamin J. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin J. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies Hit paper breakdown → | 2013 | 657 |
| 2 | 2012 | 163 | |
| 3 | 2005 | 117 | |
| 4 | 2019 | 66 | |
| 5 | 2019 | 66 | |
| 6 | 2016 | 49 | |
| 7 | 2023 | 36 | |
| 8 | 2022 | 23 | |
| 9 | 2016 | 22 | |
| 10 | 2014 | 21 | |
| 11 | 2018 | 16 | |
| 12 | 2014 | 14 | |
| 13 | 2016 | 8 | |
| 14 | 2017 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2017 | 5 | |
| 17 | 2019 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2019 | 3 |
About Benjamin J. Chen
Benjamin J. Chen is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Immunology and Hematology, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers), Single-cell and spatial transcriptomics (3 papers), Viral-associated cancers and disorders (3 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (548 citations), Oncology (820 citations), Immunology (495 citations), Genetics (105 citations) and Rheumatology (146 citations). Benjamin J. Chen has collaborated with scholars based in United States, Netherlands and Russia. Frequent co-authors include Christopher D.�M. Fletcher, Scott J. Rodig, Hongbo Yu, Margaretha G.M. Roemer, Bjoern Chapuy, Margaret A. Shipp, Jing Ouyang, Mina L. Xu, Gordon J. Freeman and Heather H. Sun. Their work appears in journals such as The American Journal of Surgical Pathology, Oncotarget, Clinical Cancer Research, Scientific Reports and Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.